Feb 26, 2026 04:05PM
Feb 3, 2026 07:05AM
Feb 3, 2026 07:00AM
Dec 16, 2025 12:18PM
Apr 9, 2025 05:00AM
Feb 26, 2025 04:05PM
Dec 3, 2024 08:01AM Relay Therapeutics (RLAY) and Elevar Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors
Dec 3, 2024 08:01AM
Dec 3, 2024 08:00AM
Nov 6, 2024 04:05PM
Oct 14, 2024 07:22AM
Sep 9, 2024 03:20PM
Sep 9, 2024 06:57AM
Sep 9, 2024 06:55AM Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival
Jun 6, 2024 07:00AM
Jun 6, 2024 07:00AM
May 25, 2023 05:03PM
May 25, 2023 05:01PM
Feb 23, 2023 04:05PM
Feb 23, 2023 04:05PM
Sep 12, 2022 08:44AM Pre-Open Stock Movers: Bristol-Myers Jumps on FDA Approval, Carvana Gains on Upgrade
Sep 12, 2022 06:31AM
Sep 12, 2022 06:30AM
Sep 12, 2022 05:38AM
Sep 11, 2022 09:45AM
Sep 11, 2022 09:45AM
Aug 4, 2022 04:05PM
Aug 4, 2022 04:05PM Relay Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights
Jun 27, 2022 06:01AM
Jun 27, 2022 06:00AM
Jun 27, 2022 06:00AM
May 5, 2022 04:05PM
May 5, 2022 04:05PM
Feb 24, 2022 04:05PM
Feb 24, 2022 04:05PM Relay Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights
Dec 10, 2021 07:31AM
Dec 10, 2021 07:30AM
Dec 10, 2021 07:30AM
Oct 12, 2021 09:29AM
Oct 11, 2021 06:03PM
Oct 7, 2021 08:50AM
Oct 7, 2021 08:50AM Relay Therapeutics Announces Preclinical Data that Support RLY-2608 as the First Known Allosteric Pan-Mutant Selective Inhibitor of PI3Kα
Oct 7, 2021 08:50AM
Sep 3, 2020 04:05PM
Sep 3, 2020 04:05PM
Aug 27, 2020 06:50AM
Aug 27, 2020 06:50AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All